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Aim: To present the long-term results of our 158 endovenous laser ablation (EVLA) procedures.
Materials and methods: From June 2008 to December 2011, 158 patients (89 women, 69 men; mean age: 38.2 years, range: 27–65) were
treated with EVLA for venous insufficiency in 192 lower limbs. All patients were symptomatic and the majority had a class 4 or higher
clinical disease (CEAP classification). A 980-nm diode laser was used under general anesthesia combined with local tumescent anesthesia
to deliver 100 to 140 laser applications along the course of the vein. Compression bandages were applied for 2 weeks postoperatively.
Follow-up exams were done by Doppler ultrasound exam at 4 weeks, 6 months, 1 year, and 2 years.
Results: A total of 192 great saphenous veins were ablated, achieving a 99% clinical success rate. Postoperative complications were mild
and well tolerated. Of the 2 (1.0%) recanalized target veins, 2 were successfully treated with a second EVLA procedure. After 3 to 6
months of EVLA treatment, 99% of the patients had significant relief of their symptoms. All patients returned to normal activity within
2 days.
Conclusion: EVLA for symptomatic saphenous vein incompetence is a minimally invasive and successful technique in resolving
varicose veins and reducing symptoms.
Key words: Venous insufficiency, laser ablation, saphenous vein

1. Introduction
Venous disease is a quite common disease affecting about
25% of the female and 15% of the male population. The
main cause of venous insufficiency is primary valvular
incompetence. Mild venous disease can cause some clinical
complaints as it worsens but is usually asymptomatic.
Reflux within the saphenous vein, which results in distal
varicose changes, is the underlying cause of varicose veins
in most cases (1).
There are a number of treatment options for saphenous
vein incompetence, such as striping, sclerotherapy, ligation,
and endovenous laser ablation. Both ligation of the great
saphenous vein (GSV) and striping have previously been
used as a surgical treatment; however, recurrence rates
of up to 40% at 5 years have been observed. Even in
the absence of complications, significant postoperative
morbidity have been associated with the surgery (2,3).
In recent years, new methods of minimally invasive
* Correspondence: omeretlik@yahoo.com
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endovenous interventions have been introduced (3,4).
In this study, we present our long-term results of 192
incidences of this less invasive endovenous laser ablation
(EVLA) treatment.
2. Materials and methods
A total of 158 patients (89 women, 69 men; mean age: 38.2
years, range: 27–65) were included for EVLA treatment for
venous insufficiency in 192 lower limbs from June 2008 to
December 2011. All patients had symptomatic venous insufficiency. Doppler ultrasonography (US) was performed
in all patients and EVLA was carried out in those with
grade 3 and 4 venous incompetence (Figures 1a and 1b).
Written informed consent, which delineated the reported
initial success of the procedure and potential complications, was obtained. Before the laser ablation, a Doppler
US examination was performed in order to delineate the
varicose vein course on the skin. Under general anesthesia,
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Figure 1. A 28-year-old man with symptoms of venous insufficiency. Doppler US shows the dilatation of a saphenous vein (a) and
the retrograde flow with the Valsalva maneuver (b).

the veins were punctured with a 21-gauge needle under US
guidance while the patient was in an upright position on
a tiltable table. After the vein was punctured, a 0.889-mm
guidewire was inserted into the vein, and then a 5F sheath
was placed over the wire up to the saphenofemoral junction (SFJ). We then made the last check to ensure that the
tip of the laser fiber was located 2–3 cm distal from the SFJ.
In order to generate sufficient heat to cause thermal
damage, a 980-nm diode laser (Intros, Germany) was used.
The laser energy damages the vein walls and results in an
occlusion in vessel lumen. The tumescent anesthesia (1000
mL isotonic, 7.5 mL 10% jetmonal, 100 mL 8.4% sodium
bicarbonate, and 0.5 mL adrenaline) was carried out and
the anesthetic solution was injected around the saphenous
vein. This solution provides a compression effect on the
veins, thus preventing thermal damage to the surrounding
structures. The sheath and probe were removed together
in 1- to 2-mm increments; 100 to 140 laser applications (at
15 W/s for the first 2 cm and 13 W/s for the remainder of
the vein) were used in a treatment. The chosen parameters
for ablation were as follows: power 10–15 W, duration 1 s,
interval 1. We used lower energy levels for smaller veins
and higher energy levels for larger veins. In all patients,
phlebectomy was also performed for varicosities after the
EVLA procedure.
After the procedure, patients were discharged and
instructed to keep the 3-layer compression wrap on for 2
days. They were asked to wear custom-made compression
stockings, except during sleeping and showering, until
their first follow-up appointment at 4 weeks. Each
patient was prescribed 600 mg of ibuprofen for its
antiinflammatory effect. On the first postoperative visit,
all patients underwent Doppler US of the target vein to
confirm thrombotic occlusion and demonstrate evidence
of wall thickening. Future visits were scheduled depending

on the physical exam findings and symptoms. Followup examinations were done at 4 weeks, 6 months, 1 year,
and 2 years. We performed a 2-year follow-up exam on
98 patients, a 1-year follow-up exam on 32 patients, and a
6-month follow-up exam on 28 patients.
3. Results
We performed laser ablation in all the patients
concomitant with phlebectomy. Eight tortuous GSVs
could not be cannulated, and thus an antegrade approach
was performed. We punctured the proximal saphenous
segment under sonographic guidance just distal to the SFJ.
In 98 patients examined more than 2 years after
the EVLA, no recurrent varicosities were seen; instead,
Doppler US demonstrated a thin, fibrous cord in the area
of the previously ablated vein (Figure 2). Furthermore,
28 patients also had no recurrence despite a short time of
follow-up period (6 months).

Figure 2. After 6 months, follow-up Doppler US showed a totally
occluded saphenous vein seen as a thin linear echogenicity.
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Before treatment, all patients had symptoms; however,
84% of patients claimed their symptoms diminished after
the treatment. Among all responders, satisfaction with the
procedure was significantly favorable.
Postprocedural Doppler US revealed 2 (1%) recurrent
varicose veins just distal to the ablated veins at the 6-month
follow-up exam. For these patients, some perforated
vessels occurred and resulted in a distal dilated vessel.
The previous EVLA procedure ended just proximal to the
knee, and in the course of time some developed collateral
vessels and perforated veins were joined to the saphenous
vein around the knee. As a result, recurrent varicose vessels
occurred. We performed a second laser ablation procedure
to the distal segment of the saphenous vein.
There was no deep vein thrombosis (DVT) or severe
nerve injury, but 44 patients experienced mild indurations
and 32 ecchymoses along the course of the ablated vein
after the procedure; these symptoms usually abated after
about 2 weeks. None of the patients had DVT or evidence
of thrombus protruding into the common femoral vein.
One patient had minimal nerve injury, which subsided
spontaneously in 2 weeks.
4. Discussion
Venous diseases affect 25% of the female and 15% of
the male population. The venous reflux at the SFJ is the
most common cause of this disease. Generally, venous
enlargement does not cause any symptoms (5). The most
common treatment has been the ligation and striping
of the GSV. The EVLA treatment has been used as an
alternative treatment since 1998 (1–3).
Surgical treatment is painful and requires a long
hospital stay. In addition, high rates of recurrence are
observed with surgical treatment. One study shows that as
much as a 29% recurrence rate has been reported (4–7).
EVLA treatment was first reported in 1999. The main
mechanism behind this method causes thermal damage
to the blood vessel wall and results in vein wall fibrosis.
EVLA has demonstrated a 90% success rate over several
years. Endovenous ablation has several advantages over
conventional surgical procedures, such as a lower level of
postoperative pain, an earlier recovery, and a reduction
in cost. Large-scale studies have shown an approximately
100% technical success rate and a long-term success rate
(up to 5 years) ranging from 90% to 100% (7–9). Our study
showed that EVLA has an approximately 99% success rate.
The success rate of saphenous vein occlusion ranges
from 88% to 100% due to the various laser systems that
vary in wavelength (8,9). According to Dexter (10),
wavelengths of a particular range (810 nm versus 980 nm)
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were determined to be insufficient for GSV treatment. The
study’s result displayed positive effects, which favored a 980nm wavelength laser. Bruising at the site, postprocedural
pain, and phlebitis were minimal. Therefore, we preferred
an endovenous laser with a wavelength of 980 nm for our
study. We achieved 100% technical success and a 99%
closure rate after 6 and 12 months.
The risks associated with this procedure include
bruising, phlebitis, brown stains on the skin, infection,
and incomplete closure. Bruising is most common and
was seen in 44% of our patients, which was minimal,
moderate, or even extensive. Bruising can last up to 1–2
weeks, but in some cases it can be visible for months.
Another minor complication is phlebitis, which can make
the area become painful and tender, or can cause some
skin discoloration. Another postablation change observed
are brown stains on the skin, which are caused by iron
from the blood. This is usually minor and resolves over
the course of a few months. Occasionally, they are darker
and can last for several months to a couple of years. The
rest of the minor complications rarely occur and have
no clinical significance. Hospital stay is less than in
surgical treatment, as in our cases. Serious complications
following an EVLA are uncommon (3,4). DVT is one of
the important complications related to the procedure. The
reported incidence of DVT related to the procedure is 1%,
but we had no case of DVT in our study. We think that
early mobilization, use of effective tumescent anesthesia,
and wearing of compression stockings were effective in
preventing DVT.
We had 2 recurrent varicose veins just distal to the
ablated veins at the 6-month follow-up exam. In these
patients, some perforated vessels occurred and resulted in
a distal dilated vessel. The previous EVLA procedure had
ended just proximal to the knee, and with time collateral
vessels and perforated veins had joined to the saphenous
vein around the knee. We had to perform a second EVLA
procedure on these patients. We thought that performing
EVLA on a more distal segment of the GSV might have
prevented the recurrence in these patients. We concluded
that the EVLA should be made as long as possible and
should end just distal to the knee in order to prevent
recurrence.
EVLA is an effective, safe, and successful method for
treating an incompetent saphenous vein. This method has
various advantages over surgical ligation and stripping.
Concomitant phlebectomy with EVLA prolonged the
procedure, but reduced the need for secondary procedures
and significantly improved the quality of life and the
severity of the patient’s venous disease.
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